Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Shares Issued (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Shares Issued for 14 consecutive years, with $465000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 99.12% to $465000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $493000.0 through Dec 2025, down 99.21% year-over-year, with the annual reading at $493000.0 for FY2025, 99.08% down from the prior year.
  • Shares Issued hit $465000.0 in Q4 2025 for Cardiff Oncology, up from $25000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $53.0 million in Q4 2024 to a low of -$18.0 million in Q4 2021.
  • Historically, Shares Issued has averaged $5.8 million across 4 years, with a median of $465000.0 in 2025.
  • Biggest YoY gain for Shares Issued was 26.3% in 2021; the steepest drop was 404.44% in 2021.
  • Year by year, Shares Issued stood at -$18.0 million in 2021, then surged by 100.42% to $75000.0 in 2022, then skyrocketed by 70629.33% to $53.0 million in 2024, then crashed by 99.12% to $465000.0 in 2025.
  • Business Quant data shows Shares Issued for CRDF at $465000.0 in Q4 2025, $25000.0 in Q3 2025, and $3000.0 in Q1 2025.